213 related articles for article (PubMed ID: 10654899)
1. Salvage cryotherapy for recurrent prostate cancer after radiation therapy: the Columbia experience.
de la Taille A; Hayek O; Benson MC; Bagiella E; Olsson CA; Fatal M; Katz AE
Urology; 2000 Jan; 55(1):79-84. PubMed ID: 10654899
[TBL] [Abstract][Full Text] [Related]
2. Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence.
De La Taille A; Benson MC; Bagiella E; Burchardt M; Shabsigh A; Olsson CA; Katz AE
BJU Int; 2000 Feb; 85(3):281-6. PubMed ID: 10671882
[TBL] [Abstract][Full Text] [Related]
3. Salvage cryotherapy with third-generation technology for locally recurrent prostate cancer after radiation therapy.
Lian H; Yang R; Lin T; Wang W; Zhang G; Guo H
Int Urol Nephrol; 2016 Sep; 48(9):1461-6. PubMed ID: 27300004
[TBL] [Abstract][Full Text] [Related]
4. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience.
Ghafar MA; Johnson CW; De La Taille A; Benson MC; Bagiella E; Fatal M; Olsson CA; Katz AE
J Urol; 2001 Oct; 166(4):1333-7; discussion 1337-8. PubMed ID: 11547068
[TBL] [Abstract][Full Text] [Related]
5. Salvage cryotherapy for local recurrence after radiotherapy for prostate cancer.
Kvorning Ternov K; Krag Jakobsen A; Bratt O; Ahlgren G
Scand J Urol; 2015 Apr; 49(2):115-9. PubMed ID: 25428754
[TBL] [Abstract][Full Text] [Related]
6. Salvage radiotherapy for prostate cancer recurrence after cryosurgical ablation.
Burton S; Brown DM; Colonias A; Cohen J; Miller R; Rooker G; Benoit R; Merlotti L; Quinn A; Kalnicki S
Urology; 2000 Nov; 56(5):833-8. PubMed ID: 11068312
[TBL] [Abstract][Full Text] [Related]
7. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of prostate specific antigen nadir after salvage cryotherapy.
Greene GF; Pisters LL; Scott SM; Von Eschenbach AC
J Urol; 1998 Jul; 160(1):86-90. PubMed ID: 9628611
[TBL] [Abstract][Full Text] [Related]
9. Salvage Cryoablation for Radiorecurrent Prostate Cancer: Initial Experience at a Regional Health Care System.
Safavy S; Jabaji RB; Lu SM; Slezak JM; Cosmatos HA; Williams SG; Finley DS
Perm J; 2019; 23():. PubMed ID: 31050644
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and complications of salvage cryotherapy of the prostate.
Pisters LL; von Eschenbach AC; Scott SM; Swanson DA; Dinney CP; Pettaway CA; Babaian RJ
J Urol; 1997 Mar; 157(3):921-5. PubMed ID: 9072600
[TBL] [Abstract][Full Text] [Related]
11. Patient selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy.
Pisters LL; Perrotte P; Scott SM; Greene GF; von Eschenbach AC
J Clin Oncol; 1999 Aug; 17(8):2514-20. PubMed ID: 10561317
[TBL] [Abstract][Full Text] [Related]
12. Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy.
Spiess PE; Lee AK; Leibovici D; Wang X; Do KA; Pisters LL
Cancer; 2006 Jul; 107(2):275-80. PubMed ID: 16770783
[TBL] [Abstract][Full Text] [Related]
13. Salvage cryosurgery for locally recurrent prostate cancer after primary cryotherapy.
Chang X; Liu T; Zhang F; Zhao X; Ji C; Yang R; Gan W; Zhang G; Li X; Guo H
Int Urol Nephrol; 2015 Feb; 47(2):301-5. PubMed ID: 25510358
[TBL] [Abstract][Full Text] [Related]
14. Cryosurgical ablation of prostate cancer: patterns of cancer recurrence.
Shinohara K; Rhee B; Presti JC; Carroll PR
J Urol; 1997 Dec; 158(6):2206-9; discussion 2209-10. PubMed ID: 9366345
[TBL] [Abstract][Full Text] [Related]
15. Predictors of biochemical failure in patients undergoing prostate whole-gland salvage cryotherapy: a novel risk stratification model.
Spiess PE; Levy DA; Mouraviev V; Pisters LL; Jones JS
BJU Int; 2013 Aug; 112(4):E256-61. PubMed ID: 23469778
[TBL] [Abstract][Full Text] [Related]
16. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy.
Pisters LL; Leibovici D; Blute M; Zincke H; Sebo TJ; Slezak JM; Izawa J; Ward JF; Scott SM; Madsen L; Spiess PE; Leibovich BC
J Urol; 2009 Aug; 182(2):517-25; discussion 525-7. PubMed ID: 19524984
[TBL] [Abstract][Full Text] [Related]
17. Third-generation salvage cryotherapy for radiorecurrent prostate cancer: a centre's experience.
Philippou P; Yap T; Chinegwundoh F
Urol Int; 2012; 88(2):137-44. PubMed ID: 22285952
[TBL] [Abstract][Full Text] [Related]
18. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
Kupelian PA; Katcher J; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
[TBL] [Abstract][Full Text] [Related]
19. Short-term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy.
Bales GT; Williams MJ; Sinner M; Thisted RA; Chodak GW
Urology; 1995 Nov; 46(5):676-80. PubMed ID: 7495120
[TBL] [Abstract][Full Text] [Related]
20. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
